Loading…
Loading…
ZEO's Q2 revenues decline y/y on fewer solar installations, while higher labor and domestic-content material costs compress the gross margin.
1H 2026 revenue increased 9.2% Continued focus on identifying accretive commercial opportunities and controlling costs NEW PORT RICHEY, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a provider of residential solar and commercial long-duration energy-storage solutions, today reported financial results for the second quarter and first half ended June 30, 2026.
Hosted at Fort Lauderdale's newly reimagined Pier Sixty-Six Resort, the inaugural event combines cutting-edge biologics education, hands-on clinical training, practice growth strategies, and latest innovations. FORT LAUDERDALE, FL / ACCESS Newswire / August 4, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company"), a biologics research and products company advancing regenerative medicine, physician education, and next-generation biologic technologies, today announced the launch of ZEO Xperience, the Company's inaugural three-day immersive educational experience designed exclusively for healthcare professionals seeking to expand their knowledge of regenerative biologics, strengthen clinical expertise, and learn best practices for responsibly integrating advanced biologic therapies into patient care.
NEW PORT RICHEY, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo” or the “Company”), a diversified provider of residential solar power and commercial long-duration energy-storage solutions, today highlighted strengthening demand for residential solar power and energy storage as homeowners seek greater control over rising electricity costs amid increasing pressure on regional power grids.
Operating from Nova Southeastern University's Center for Collaborative Research, ZEO ScientifiX is expanding physician education, scientific collaboration, and regenerative biologic innovation as Florida emerges as a national life sciences hub. DAVIE, FL / ACCESS Newswire / July 21, 2026 / As Florida rapidly emerges as one of the nation's leading destinations for biotechnology and life sciences, ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") is strengthening its role within South Florida's growing healthcare innovation ecosystem through regenerative biologic research, development, physician education, and scientific collaboration.
Company reports revenue growth of 124.6% for the quarter ended April 30, 2026 and 79.9% for the six months ended April 30, 2026, as compared to the same periods one year earlier as commercial momentum accelerates across its regenerative biologics portfolio DAVIE, FL / ACCESS Newswire / July 8, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company"), a biologics research and products company advancing regenerative medicine, physician education, and next-generation biologic technologies, today announced that it had reported exceptional year-over-year revenue growth, stronger gross margins, and improved operating performance in its recently filed Form 10-Q for the Quarter ended April 30, 2026 (the "Form 10-Q"). In the Form 10-Q, the Company provided the following information: "Revenues.
"One Year Later, Three States Stronger" program will examine lessons learned from Florida's first year into their pioneering stem cell law and provide physicians from other states an insight of what to prepare for as their state stem cell therapy laws are enacted. DAVIE, FL / ACCESS Newswire / July 1, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company"), a biologics research and products company dedicated to advancing regenerative medicine and physician education, today announced that it will host a live virtual educational webinar for healthcare professionals, titled "One Year Later, Three States Stronger: The Southeast Regen Revolution," on July 22, 2026, at 6:45 p.m.
Company strengthens scientific leadership as regenerative medicine gains national momentum DAVIE, FL / ACCESS Newswire / June 9, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company"), a biologics research and products company and a leader in educating physicians on the science of regenerative medicine, today announced the expansion of its Medical Advisory Board with the addition of nine highly-recognized physicians and scientific innovators across key disciplines in regenerative and longevity medicine. As access to regenerative medicine in the United States expands, with states such as Georgia and Tennessee and others expected to follow Florida in advancing supportive legislation, ZEO ScientifiX continues to focus on deepening its scientific foundation by assembling a multidisciplinary advisory board spanning orthopedics, oncology, longevity science, pain management, plastic surgery, and advanced biologic therapies.